Tuesday, 3 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange
Annual Report

Kilitch Drugs(I) Annual Report

Kilitch Drugs submitted its Annual Report for FY 2025-26 and the notice for the 34th Annual General Meeting to the stock exchanges.

Source

BSE filing, NSE: KILITCH. Summary written from the filing by ALFA Finder's alert engine.

Read the filing ↗

Kilitch Drugs(I) Ltd: key numbers

Share price
₹202.13
Market cap
₹706.7 Cr
Revenue (annual)
₹235.5 Cr
Net profit (annual)
₹30.17 Cr
P/E (TTM)
23.5×Sector 47.2×
Promoter holding
63.77%+0.00% QoQ
FII holding
0.10%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

More from Kilitch Drugs(I) Ltd

All →

Other annual report announcements

All →